The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries

Jia, 2020, Cutaneous manifestations of COVID-19: a preliminary review, J Am Acad Dermatol, 83, 687, 10.1016/j.jaad.2020.05.059

Fernandez-Nieto, 2020, Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak, J Am Acad Dermatol, 83, e61, 10.1016/j.jaad.2020.04.093

Piccolo, 2020, Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients, J Eur Acad Dermatol Venereol, 34, e291, 10.1111/jdv.16526

Recalcati, 2020, Acral cutaneous lesions in the time of COVID-19, J Eur Acad Dermatol Venereol, 34, e346, 10.1111/jdv.16533

Bouaziz, 2020, Vascular skin symptoms in COVID-19: a French observational study, J Eur Acad Dermatol Venereol, 10.1111/jdv.16544

Galvan Casas, 2020, Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases, Br J Dermatol, 183, 71, 10.1111/bjd.19163

Freeman, 2020, Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries, J Am Acad Dermatol, 83, 486, 10.1016/j.jaad.2020.05.109

Recalcati, 2020, Cutaneous manifestations in COVID-19: a first perspective, J Eur Acad Dermatol Venereol, 34, e212

de Masson, 2020, Chilblains are a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France, J Am Acad Dermatol, 83, 667, 10.1016/j.jaad.2020.04.161

Marzano, 2020, Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients, J Am Acad Dermatol, 83, 280, 10.1016/j.jaad.2020.04.044

Sanchez, 2020, Digitate papulosquamous eruption associated with severe acute respiratory syndrome coronavirus 2 infection, JAMA Dermatol, 10.1001/jamadermatol.2020.1704

Diaz-Guimaraens, 2020, Petechial skin rash associated with severe acute respiratory syndrome coronavirus 2 infection, JAMA Dermatol, 10.1001/jamadermatol.2020.1741

Zhang, 2020, Zhonghua Xue Ye Xue Za Zhi, 41, E006

Magro, 2020, Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases, Transl Res, 220, 1, 10.1016/j.trsl.2020.04.007

Tong, 2020, The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis, Otolaryngol Head Neck Surg, 163, 3, 10.1177/0194599820926473

Freeman, 2020, The AAD COVID-19 registry: crowdsourcing dermatology in the age of COVID-19, J Am Acad Dermatol, 83, 509, 10.1016/j.jaad.2020.04.045

Evaluating and testing persons for coronavirus disease 2019 (COVID-19). https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html. Accessed May 19, 2020.

Rabin

Cha

Zakraoui, 1988, Tunis Med, 66, 821

Suchonwanit, 2020, Cutaneous manifestations in COVID-19: lessons learned from current evidence, J Am Acad Dermatol, 83, e57, 10.1016/j.jaad.2020.04.094

Fiehn, 2017, Familial chilblain lupus—what can we learn from type i interferonopathies?, Curr Rheumatol Rep, 19, 61, 10.1007/s11926-017-0689-x

Jamilloux, 2020, Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions, Autoimmun Rev, 19, 102567, 10.1016/j.autrev.2020.102567

Zhang, 2020, Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19, J Infect Dis, 222, 34, 10.1093/infdis/jiaa224

De Giorgi, 2020, Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): a prospective study from China and Italy, J Am Acad Dermatol, 83, 674, 10.1016/j.jaad.2020.05.073

Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032

Madigan, 2020, How dermatologists can learn and contribute at the leading edge of the COVID-19 global pandemic, JAMA Dermatol, 10.1001/jamadermatol.2020.1438

Lester, 2020, Absence of skin of colour images in publications of COVID-19 skin manifestations, Br J Dermatol, 10.1111/bjd.19258

Dyer, 2020, Covid-19: black people and other minorities are hardest hit in US, BMJ, 369, m1483, 10.1136/bmj.m1483

Laurencin, 2020, The COVID-19 pandemic: a call to action to identify and address racial and ethnic disparities, J Racial Ethn Health Disparities, 7, 398, 10.1007/s40615-020-00756-0

To, 2020, Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study, Lancet Infect Dis, 20, 565, 10.1016/S1473-3099(20)30196-1

Zhang, 2020, Coagulopathy and antiphospholipid antibodies in patients with Covid-19, N Engl J Med, 382, e38, 10.1056/NEJMc2007575

Wu, 2020, Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications, MedRχiv

Whitman, 2020, Test performance evaluation of SARS-CoV-2 serological assays, MedRχiv

Wang, 2020, Neutralizing antibodies responses to SARS-CoV-2 in COVID-19 inpatients and convalescent patients, MedRχiv